American Society Wasn’t Always So Car-Centric. Our Future Doesn’t Have To Be, Either.
The surprising history of the car in the U.S. offers hope for a shift toward more climate-friendly transportation options.
Read more...The surprising history of the car in the U.S. offers hope for a shift toward more climate-friendly transportation options.
Read more...While a UK crisis is not yet brewing, there are plenty of worrisome developments that could keep moving in the wrong direction.
Read more...Dollar General has launched profit-motivated health clinics on wheels. What could go wrong?
Read more...eBay is often accused of selling fakes, like knockoff Hermes ties. The Feds are suing eBay for selling real, as in really dangerous, wares
Read more...Recession complacency means things are wobblier than they seem.
Read more...Sadly, famed short seller David Einhorn’s saying applies to US public health: “No matter how bad you think it is, it’s worse.”
Read more...McKinsey’s latest payoff to avoid admiting culpability reveals some of the inherent problems with high-end management consulting.
Read more...The much-delayed appointment of a new FCC chair sets up the agency to roll back an anti-internet-freedom rule change under Trump.
Read more...After many years, concerns about the impact of fracking on aquifers are finally going mainstream.
Read more...Bank lobbyists want to weaken bank regulations even after rich stakeholders in recent “not-to-big-to-fail “bank failures were rescued.
Read more...Workers adjust their immediate labour supply in response to the income effects caused by changes to future pensions.
Read more...The cheap and highly addictive cocaine-like stimulant Captagon shows signs of following in the opioid fentanyl’s footsteps.
Read more...Sadly, there is pushback against a proposed Medicare rule to assure (barely) adequate staffing in nursing homes. Please comment in favor!
Read more...The “liquidity” support provided by the Fed to megabanks through cross-border lending in fact acted as subsidies.
Read more...Demand that state legislators investigate pharmacy benefit manager price-gouging for biologics like Humira when cheaper biosimilars exist
Read more...